The story of Sildenafil presents a complex picture for investors. While the initial introduction generated massive returns, the lapse of its exclusive rights opened the avenue to off-brand competitors, dramatically https://socialdosa.com/story11676550/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet